Isoformix is a biotech company focusing on discovering new targets and therapies for Alzheimer's disease  

Isoformix has a suite of mass spectrometry-based tests targeting protein isoforms biomarkers with clinical significance in the development and progression of Alzheimer's disease

Isoformix is collaborating with clinical researchers around the world, using its proprietary technology and tests to provide new insights into the pathophysiology of Alzheimer's disease and to discover new therapeutic targets.